For the quarter ending 2025-09-30, IOVA has $904,948K in assets. $202,661K in debts. $158,134K in cash and cash equivalents.
| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 158,134 | 132,469 | ||
| Trade accounts receivable | 66,761 | 59,938 | ||
| Short-term investments | 142,669 | 168,714 | ||
| Inventory | 51,710 | 49,833 | ||
| Prepaid expenses and other assets | 9,817 | 11,546 | ||
| Total current assets | 429,091 | 422,500 | ||
| Property and equipment, net | 126,650 | 122,473 | ||
| Intangible assets, net | 285,208 | 296,253 | ||
| Operating lease right-of-use assets | 48,763 | 49,949 | ||
| Restricted cash | 5,965 | 5,944 | ||
| Long-term assets | 9,271 | 10,318 | ||
| Total assets | 904,948 | 907,437 | ||
| Accounts payable | 31,237 | 32,004 | ||
| Accrued expenses and other liabilities | 87,267 | 89,081 | ||
| Note payable - current | 1,000 | 1,000 | ||
| Operating lease liabilities | 6,281 | 7,070 | ||
| Total current liabilities | 125,785 | 129,155 | ||
| Operating lease liabilities - non-current | 45,211 | 45,096 | ||
| Deferred tax liabilities | 31,665 | 34,698 | ||
| Total non-current liabilities | 76,876 | 79,794 | ||
| Total liabilities | 202,661 | 208,949 | ||
| Preferred stock, value-Series APreferred Stock | 0 | 0 | ||
| Preferred stock, value-Series BPreferred Stock | 2 | 2 | ||
| Common stock, 0.000041666 par value 500,000,000 shares authorized, 385,461,728 and 305,252,194 shares issued and outstanding as of september 30, 2025 and december 31, 2024, respectively | 16 | 14 | ||
| Accumulated other comprehensive loss (income) | 16,103 | 20,859 | ||
| Additional paid-in capital | 3,389,792 | 3,289,986 | ||
| Accumulated deficit | -2,703,626 | -2,612,373 | ||
| Total stockholders' equity | 702,287 | 698,488 | ||
| Total liabilities and stockholders' equity | 904,948 | 907,437 | ||
IOVANCE BIOTHERAPEUTICS, INC. (IOVA)
IOVANCE BIOTHERAPEUTICS, INC. (IOVA)